Co-Founder and CEO, DNAnexus
Founder and CEO, Acme Packet
Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
VP of Research & Policy, Ewing Marion Kauffman Foundation
Join Prescience for lunch to hear from David Kirn, a global leader in the clinical research and development of oncolytic viruses for cancer. Kirn will talk about Jennerex Biotherapeutics, one of the Bay Area’s most promising clinical-stage biotherapeutics companies. Jennerex’s lead product is currently in a Phase 2b clinical trial for hepatocellular carcinoma and Phase 1/2 clinical development for colorectal cancer. Kirn will share insights into the science on which Jennerex is based, tips for founding a successful start-up, and his vision for the future of the life sciences. More information and online registration is here.